Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 123 results for "ranbaxy lab"

Religare Enterprises to split into three independent listed units

MUMBAI: Religare Enterprises, the company majority owned by the family that once were the promoters of Ranbaxy Labs, on Friday decided to split into three independent listed entities handling lending operations through the NBFC arm, running the ... Times of India, 1 month ago

Ranbaxy ex-bosses to challenge Rs2,562-cr fine for hiding info from Daiichi

Malvinder and Shivinder Singh, the original promoters of Ranbaxy Laboratories, will challenge the order of a Singapore tribunal imposing a Rs2,562-crore ($400 million) penalty on them for concealing information from Japan's Daiichi Sankyo while ...
 Domain-B1 month ago Malvinder and Shivinder Mohan Singh to contest arbitration panel order on damages to Daiichi  Economic Times1 month ago

Bhupesh Bhandari: Listen to Dinesh Thakur

Dinesh Thakur, the Ranbaxy whistleblower, seems to be waging a lone battle against sub-standard medicine. After the Supreme Court threw out his plea that sought "the creation of a framework for the recall of drugs and a commission to examine faulty ...
 Smart Investor1 month ago

Sun Pharma selling off two more US facilities

Dive Brief: As part of its integration of Ranbaxy Labs, which Sun Pharma acquired last year, the largest pharma company in India is selling two US-based locations. The facilities. located in Philadelphia and Aurora, IL,are being sold to Frontida ...
 BioPharma Dive2 weeks ago India and Nacimbio in MoU on hep C, HIV therapies  FiercePharma6 days ago German packaging giant Uhlmann to invest 5 million euros to expand its footprint in India  PharmaBiz1 month ago Can Indian pharma fight back?  Hindu Business Line1 month ago

Fracas at pharma firm's meeting to discuss transfers

Nagpur: A meeting called by Sun Pharma to discuss transfer issues of employees took an ugly turn when field workers and the management entered into a tiff at a city hotel on Wardha Road on Saturday. The fracas forced the hotel management seek police ...
 Times of India1 day ago
International Business Times India

Allowing 74% FDI in pharma sector may attract many MNCs to invest in India

The new Foreign Direct Investment (FDI) policy 2016 allowing 74 per cent FDI through automatic route in pharmaceutical industry will open up the foreign investments in pharma industry as many foreign companies are looking for an investment in ...
 PharmaBiz2 days ago Govt's pharma FDI sop may hit affordable healthcare  Financial Express4 days ago Jaitley proposes to allow direct FDI in pharma sector; domestic companies worry over M&As  International Business Times India2 weeks ago

FDI up to 74% in brownfield pharma under automatic route

The government today allowed up to 74 per cent foreign direct investment in the existing pharmaceutical companies through automatic route, with an aim to promote the sector. Earlier, 100 per cent FDI was permitted through government approval route.
 Moneycontrol.com6 days ago

Pharma M&As: value creator or value destroyer?

Anil Khanna , Partner, Tai Pi Advisors analyses the trend of rising M&As in the pharma industry and examines its causes and implications Anil Khanna What is it with M&As that they make the adrenalin skyrocket, or generate a strong urge to go ...
 Financial Express5 days ago

Global Therapeutic Antibody Bundle Report 2016 - Focus on ADCs, Bispecifics, Biosimilars & Biosuperiors

Research and Markets has announced the addition of the "Therapeutic Antibody Reports Bundle: ADCs, Bispecifics, Biosimilars & Biosuperiors" report to their offering. The Therapeutic Antibody Reports Bundle: ADCs, Bispecifics, Biosimilars & ...
 BioSpace1 week ago Active Pharmaceutical Ingredients Global Market - Forecast to 2022  International Business Times1 week ago A Mixed Week for Global Markets  Equitymaster.com2 months ago

NHM to tie up with pvt labs for free diagnostic tests

— By | Jun 12, 2016 12:59 am BHOPAL : NHM is planning to make tests of critical diseases free for patients coming to district hospitals and for the same tenders from Ranbaxy, Dr Lal Path Labs, Thyrocare, Sugai Diagnosis, Central Lab and six other ...
 The Freepress Journal2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less